Digital biomarkers: shaping the future of medical interventions- Smart digital devices, encompassing smartphones, tablets, smartwatches and other IoT gadgets, have witnessed significant increase in their adoption, across the world.

This trend is fueled by their ever-rising functionalities, such as seamless connectivity, AI-driven personal assistants and health monitoring features (by analyzing digital biomarkers). As these devices become economical and technologically advanced, their ubiquity continues to grow.

The digital biomarkers market is estimated to be USD 5.6 billion in 2024 and is projected to reach USD 35.8 billion in 2035. The market is anticipated to grow at a CAGR of 18.48%, during the forecast period till 2035.

The global biomarkers market is a growing field with various pharmaceutical firms taking complete advantage of these tools to enhance healthcare delivery to patients. Biomarkers play a significant role in the diagnosis and monitoring of a myriad of therapeutic indications, or responses to pharmacological interventions. Technological advancements have also been noted in the biomarkers market, with the development of digital biomarkers; digital biomarkers are analyzed in silico, using advanced analytical algorithms and artificial intelligence (AI) enabled tools, and thus, can be used to rapidly generate actionable insights and identify previously undetected biological events (obscured by the shortcomings of manual processes).

Owing to their multiple benefits, including ease of access, versatile platforms, decreased cost of treatment, personalized treatment options, enhanced medication adherence, promotion of healthy lifestyle and remote access to healthcare providers for patients and vice versa, digital biomarkers have emerged as a promising alternative to conventional medication. The benefits offered by these solutions and the growing demand for remote and digital solutions across the world, post the pandemic, are likely to drive the market growth in the long term.

The current market landscape features the presence of more than 220 digital biomarkers that are currently available in the market or under different stages of development. Majority of digital biomarker solutions are software / applications. Notably, 5% of the digital biomarker solutions can be used for data collection / analysis as well as for data integration. Further, most of the digital biomarker solutions are intended for neurological disorders, followed by oncological disorders (including breast cancer, lung cancer and prostate cancer) and cardiovascular disorders (including hypertension, cardiac arrhythmias and arterial stiffness).

In the realm of health monitoring, digital solutions have evolved to measure a wide array of biomarkers. Most of the digital biomarker solutions collect / analyze / integrate information related to different physiological biomarkers, such as pulse rate, heart rate variability, sweat parameters and body temperature.

Around 65% of the digital biomarker solutions are used for monitoring patients suffering from a wide range of disorders, thereby providing real-time insights of their health. This is followed by solutions that are used for diagnosis and early detection / screening of diseases. Further, over 90% of these solutions are intended to be used by adults.

Research Methodology

Our analysts have performed an accurate examination of the various aspects of the global market leveraging avant-garde primary and secondary sources of data collection. The report has gathered the necessary data and information from several reliable sources. Additionally, the report offers many strategic recommendations for companies involved in this ever-growing business sector to help them attain a competitive edge in the Digital Biomarkers Market. 

Thank you for reading our report. Kindly get in touch with us to know more about the report or to receive a customized copy of it. Our team will ensure the report is tailored according to your needs. 

To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/digital-biomarkers-market.html

About Roots Analysis

Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.                   

We specialise in analysing areas which have lacked quality research so far or require more focused understanding within the broader industry. All our reports are structured in a way to enable the reader develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we also provide bespoke research / consulting services dedicated to serve our clients in the best possible way.

The research efforts are driven by a global team. The leadership team brings a wealth of experience within the sector. Their collective experience in pharmaceutical / affiliated domains allows us to tackle various areas of research in a structured way. We also regularly leverage our global network of experts who hold senior leadership positions in reputed firms and organisations worldwide.

Contact:

Roots Analysis

+1 (415) 800 3415

[email protected]